These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24728257)

  • 21. AIDS: Part II.
    Kessler HA; Bick JA; Pottage JC; Benson CA
    Dis Mon; 1992 Oct; 38(10):691-764. PubMed ID: 1396036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pulmonary complications in patients with AIDS].
    Oka S
    Kekkaku; 2002 Jan; 77(1):37-40. PubMed ID: 11855078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute pancreatitis. A fatal complication of AIDS therapy.
    Aboulafia DM
    J Clin Gastroenterol; 1997 Dec; 25(4):640-5. PubMed ID: 9451679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A decade of antiretroviral therapy: a profile of patients with 10 years of highly effective triple therapy].
    Wilson G; Wolff M
    Rev Chilena Infectol; 2012 Jun; 29(3):337-43. PubMed ID: 23096476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin.
    Moreno A; Quereda C; Moreno L; Perez-Elías MJ; Muriel A; Casado JL; Antela A; Dronda F; Navas E; Bárcena R; Moreno S
    Antivir Ther; 2004 Feb; 9(1):133-8. PubMed ID: 15040545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy.
    Butt AA
    AIDS Read; 2003 Jul; 13(7):344-8. PubMed ID: 12889452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
    Whitfield RM; Bechtel LM; Starich GH
    Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute onset of pancreatitis with concomitant use of tenofovir and didanosine.
    Kirian MA; Higginson RT; Fulco PP
    Ann Pharmacother; 2004 Oct; 38(10):1660-3. PubMed ID: 15340130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
    Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine. German ddI Trial Group.
    Jablonowski H; Arasteh K; Staszewski S; Ruf B; Stellbrink HJ; Schrappe M; Stoehr A; Haase W; Schomaker U; von Eisenhart Rothe B
    AIDS; 1995 May; 9(5):463-9. PubMed ID: 7639971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute pancreatitis as a common complication of 2',3'-dideoxyinosine therapy in the acquired immunodeficiency syndrome.
    Maxson CJ; Greenfield SM; Turner JL
    Am J Gastroenterol; 1992 Jun; 87(6):708-13. PubMed ID: 1590305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal lactic acidosis associated with highly active antiretroviral therapy in patients with advanced human immunodeficiency virus infection in Taiwan.
    Sheng WH; Hsieh SM; Lee SC; Chen MY; Wang JT; Hung CC; Chang SC
    Int J STD AIDS; 2004 Apr; 15(4):249-53. PubMed ID: 15075019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV disease and advanced age: an increasing therapeutic challenge.
    Manfredi R
    Drugs Aging; 2002; 19(9):647-69. PubMed ID: 12381235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
    Lancet; 1999 Jun; 353(9169):2014-25. PubMed ID: 10376616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleoside analogues and mitochondrial toxicity.
    Fleischer R; Boxwell D; Sherman KE
    Clin Infect Dis; 2004 Apr; 38(8):e79-80. PubMed ID: 15095236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Didanosine: an updated review of its use in HIV infection.
    Perry CM; Noble S
    Drugs; 1999 Dec; 58(6):1099-135. PubMed ID: 10651392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleoside reverse transcriptase inhibitor usage and the incidence of peripheral neuropathy in HIV/AIDS patients.
    Dragovic G; Jevtovic D
    Antivir Chem Chemother; 2003 Sep; 14(5):281-4. PubMed ID: 14694991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic aspects of HIV/AIDS infected patients and evaluation of therapeutic protocols].
    Reszketö Z; Szlávik J; Balogh J; Vincze Z
    Acta Pharm Hung; 2001 Dec; 71(4):428-32. PubMed ID: 12113183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.